Psilocybin - Summary of knowledge and new perspectives

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F14%3A43908424" target="_blank" >RIV/00216208:11120/14:43908424 - isvavai.cz</a>
Alternative codes found
RIV/00023752:_____/14:43914535
Result on the web
<a href="http://dx.doi.org/10.1016/j.euroneuro.2013.12.006" target="_blank" >http://dx.doi.org/10.1016/j.euroneuro.2013.12.006</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.euroneuro.2013.12.006" target="_blank" >10.1016/j.euroneuro.2013.12.006</a>

Result language
angličtina
Original language name
Psilocybin - Summary of knowledge and new perspectives
Original language description
Psilocybin, a psychoactive alkaloid contained in hallucinogenic mushrooms, is nowadays given a lot of attention in the scientific community as a research tool for modeling psychosis as well as due to its potential therapeutic effects. However, it is alsoa very popular and frequently abused natural hallucinogen. This review summarizes all the past and recent knowledge on psilocybin. It briefly deals with its history, discusses the pharmacokinetics and pharmacodynamics, and compares its action in humansand animals. It attempts to describe the mechanism of psychedelic effects and objectify its action using modern imaging and psychometric methods. Finally, it describes its therapeutic and abuse potential.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FH - Neurology, neuro-surgery, nuero-sciences
OECD FORD branch
—

Project
<a href="/en/project/NT13897" target="_blank" >NT13897: Animal and human serotonergic model of schizophrenia: validity evaluated by qEEG and fMRI.</a><br>
Continuities
S - Specificky vyzkum na vysokych skolach

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)